Insmed INSM
NASDAQ INSM
$108.15 -0.44 (-0.41%)
As of: Oct 2, 2026 · 10:19 AM EDT

Insmed (INSM) Non Operating Interest Expenses (2011 - 2026)

Updated

Insmed (INSM) reported Non Operating Interest Expenses of $20.27 million for Q2 2026, down 4.6% from $21.25 million a year earlier but up 1.0% from the prior quarter.

Analysis

Insmed (INSM) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Insmed's Non Operating Interest Expenses came in at $81.34 million, down 4.8% year-over-year; for FY2025, it was $83.8 million, down 1.3% from FY2024.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
  • By year, Non Operating Interest Expenses came in at $84.91 million in FY2024 (+3.9%), $81.69 million in FY2023 (+208.9%), $26.45 million in FY2022 (-34.7%) and $40.47 million in FY2021 (+36.9%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of $3.29 million in Q1 2022 and a high of $21.57 million in Q1 2025.
  • Year over year, Non Operating Interest Expenses has now declined in each of the last five quarters, with an average decline of 1.2% over the last eight quarters.
  • The high point for year-over-year Non Operating Interest Expenses in five years was Q2 2023 (growth of 514.2%); the low point was Q3 2022 (a decline of 70.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20.08 million (Q1 2026), $20.6 million (Q4 2025) and $20.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Insmed 24.91 Bn 19.42 Bn 358.27 Mn 20.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.27 Mn
Mar 31, 2026 20.08 Mn
Dec 31, 2025 20.60 Mn
Sep 30, 2025 20.38 Mn
Jun 30, 2025 21.25 Mn
Mar 31, 2025 21.57 Mn
Dec 31, 2024 21.55 Mn
Sep 30, 2024 21.05 Mn
Jun 30, 2024 21.27 Mn
Mar 31, 2024 21.04 Mn
Dec 31, 2023 20.78 Mn
Sep 30, 2023 20.29 Mn
Jun 30, 2023 20.62 Mn
Mar 31, 2023 20.00 Mn
Dec 31, 2022 16.45 Mn
Sep 30, 2022 3.35 Mn
Jun 30, 2022 3.36 Mn
Mar 31, 2022 3.29 Mn
Dec 31, 2021 11.35 Mn
Sep 30, 2021 11.25 Mn
API Access

Insmed Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INSM&period=max&api_key=YOUR_API_KEY